Eluceda Overview

  • Founded
  • 2009

  • Status
  • Private

  • Employees
  • 16

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $2.45M

  • Investors
  • 2

Eluceda General Information


Developer of biosensors designed to detect bacteria. The company's biosensors operate in a wide variety of environments and making sensors truly democratic and ubiquitous contributing to reducing product counterfeiting, speeding up drug production, making production safer and analyzing waste streams, enabling bio-pharmaceutical firms to detect markers in a wide variety of harsh chemicals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Decision/Risk Analysis
Diagnostic Equipment
Primary Office
  • Unit 3 Caroline Court
  • Billington Road
  • Burnley BB11 5UB
  • England, United Kingdom

Eluceda Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eluceda Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 07-Jul-2021 $2.45M 00.00 0000 Completed Generating Revenue
2. Angel (individual) 14-Sep-2020 00000 00000 000.00 Completed Generating Revenue
1. Grant 01-Jun-2015 $35.2K Completed Generating Revenue
To view Eluceda’s complete valuation and funding history, request access »

Eluceda Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Dummy 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 3,915 $0.139394 $529.85 $529.85 1x $529.85 11.93%
Ordinary 1,773 $0.139394 $393.09 $393.09 1x $393.09 5.4%
To view Eluceda’s complete cap table history, request access »

Eluceda Patents

Eluceda Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4058796-A1 Electrochemical authentication method Pending 15-Nov-2019 000000000
GB-201916696-D0 Electrochemical authentication method Inactive 15-Nov-2019
EP-2956549-A1 Assay for detecting a nucleic acid analyte in a biological sample Active 14-Feb-2013 0000000000
EP-2956549-B1 Assay for detecting a nucleic acid analyte in a biological sample Active 14-Feb-2013 0000000000
GB-201302610-D0 Assay for detecting an analyte in a biological sample Inactive 14-Feb-2013 C12Q1/6825
To view Eluceda’s complete patent history, request access »

Eluceda Executive Team (1)

Name Title Board Seat Contact Info
Matthew Harte Managing Director & Board Member
To view Eluceda’s complete executive team members history, request access »

Eluceda Board Members (6)

Name Representing Role Since
Ian Eastwood Eluceda Board Member 000 0000
Jim Murray-Smith Self Chairman 000 0000
Matthew Harte Eluceda Managing Director & Board Member 000 0000
Neil Ivey Eluceda Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Eluceda Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eluceda Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Peter Cowley Angel (individual) Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
To view Eluceda’s complete investors history, request access »